NICE recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in ...

A new study suggests that memory problems and difficulty concentrating after chemotherapy may stem from impaired lymphatic-system drainage caused by cancer drugs. Cancer is already a difficult ...

New research reveals that chemotherapy may cause “chemo brain” by damaging the brain’s lymphatic system — the network responsible for clearing waste and supporting immune function.

New research indicates chemo brain, a side effect of chemotherapy characterized by a mix of cognitive issues, is linked to ...

Cancer is a challenging enough diagnosis, but many patients are dealt a second blow, even as they heal: "chemo brain." Also called "brain fog," this mix of cognitive issues—memory problems, struggling ...

Cancer is a challenging enough diagnosis, but many patients are dealt a second blow, even as they heal: "chemo brain." Also called "brain fog," this mix of cognitive issues - memory problems, ...

Combinations of androgen deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPIs) are the accepted ...

Imfinzi plus FLOT chemotherapy significantly improves overall survival in resectable G/GEJ adenocarcinoma compared to placebo ...

Positive results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT (fluorouracil, leucovorin, ...